Thimble Point Acquisition Corp.
Status: Closed Deal
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $276.00M |
|---|---|
| IPO Date | Feb 2, 2021 |
| CEO | Elon S. Boms |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+(3) |
| IPO Sector | Technology ▶ |
| IPO Geography | Global |
| Target Company | Pear Therapuetics |
| Deal Announced | Jun 22, 2021 |
| Deal Size, $M | $1,201.30M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Nov 30, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 3, 2021 |
Formerly THMA
PEARQ
PEARW
| Price | $0.00 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.